|
(MoneyNewsWire.Net, December 31, 2015 )
3B Pharmaceuticals GmbH - Product Pipeline Review - 2015 Size and Share Published in 2015-11-25 Available for US$ 1500 at Researchmoz.us
Description
Global Markets Directs, 3B Pharmaceuticals GmbH - Product Pipeline Review - 2015, provides an overview of the 3B Pharmaceuticals GmbHs pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of 3B Pharmaceuticals GmbHs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=500151
Scope
- The report provides brief overview of 3B Pharmaceuticals GmbH including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of 3B Pharmaceuticals GmbHs human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the 3B Pharmaceuticals GmbHs pipeline products
Reasons to buy
- Evaluate 3B Pharmaceuticals GmbHs strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of 3B Pharmaceuticals GmbH in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the 3B Pharmaceuticals GmbHs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of 3B Pharmaceuticals GmbH and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of 3B Pharmaceuticals GmbH
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of 3B Pharmaceuticals GmbH and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=500151
Table of Content
Table of Contents 2
List of Tables 4
List of Figures 4
3B Pharmaceuticals GmbH Snapshot 5
3B Pharmaceuticals GmbH Overview 5
Key Information 5
Key Facts 5
3B Pharmaceuticals GmbH - Research and Development Overview 6
Key Therapeutic Areas 6
3B Pharmaceuticals GmbH - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
3B Pharmaceuticals GmbH - Pipeline Products Glance 12
3B Pharmaceuticals GmbH - Clinical Stage Pipeline Products 12
Phase 0 Products/Combination Treatment Modalities 12
3B Pharmaceuticals GmbH - Early Stage Pipeline Products 13
Discovery Products/Combination Treatment Modalities 13
3B Pharmaceuticals GmbH - Drug Profiles 14
3BP-227 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Synthetic Peptide for Cancer 15
Product Description 15
Mechanism of Action 15
Browse All Pharmaceutical Market Research Reports at http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
Contact Us:
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us <||>rnhttp://www.researchmoz.us/
For More Report Click Here @ http://www.prweb.com/search.aspx?search-releases=researchmoz&hitsPerPage=20
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
|
